EX-FILING FEES 5 d852232dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107

Calculation of Filing Fee Tables

Form S-8

(Form Type)

Vincerx Pharma, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

 

                 
    

Security

Type

 

Security

Class

Title

 

Fee

Calculation

 

Amount

Registered(1)

 

Proposed

Maximum

Offering

Price Per
Unit

 

Maximum

Aggregate

Offering

Price

 

Fee

Rate

 

Amount of

Registration

Fee

 
Newly Registered Securities
                 
Fees to Be Paid   Equity   Common Stock, $0.0001 par value per share              
                 
      To be issued under the Vincerx Pharma, Inc. 2020 Stock Incentive Plan   457(a)   2,570,375   $0.62(2)   $1,593,633   0.0001476   $236
                 
      To be issued under the Vincerx Pharma, Inc. 2021 Employee Stock Purchase Plan   457(a)   214,075   $0.53(3)   $113,460   0.0001476   $17
         
    Total Offering Amounts   $1,707,093     $253
         
    Total Fees Previously Paid      
         
    Total Fee Offsets      
         
    Net Fee Due           $253

 

(1)

Pursuant to Rule 416(a) under the Securities Act of 1933 (the “Securities Act”), this Registration Statement also covers an indeterminate number of additional shares that may be issued to adjust the number of shares issued pursuant to the plans described herein in the event of a stock dividend, stock split, reverse stock split, extraordinary dividend, extraordinary distribution, recapitalization, reorganization, merger, combination, consolidation, split-up, spin-off, combination, exchange of shares, rights offering, separation, reorganization, liquidation or similar event.

(2)

Computed in accordance with Rules 457(c) and 457(h) under the Securities Act, solely for the purposes of calculating the registration fee, based on the average of the high and low prices of the Registrant’s common stock as reported on the Nasdaq Capital Market on June 20, 2024.

(3)

Computed in accordance with Rules 457(c) and 457(h) under the Securities Act, solely for the purposes of calculating the registration fee, based on 85% of the average of the high and low prices of the Registrant’s common stock as reported on the Nasdaq Capital Market on June 20, 2024. Pursuant to the Vincerx Pharma, Inc. 2021 Employee Stock Purchase Plan, the purchase price of the shares of common stock reserved for issuance thereunder will be 85% of the lower of the fair market value of common stock on the first trading day of the offering period or on the purchase date.